or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    XGN D Exagen Inc. 6.71
    VTGN F VistaGen Therapeutics, Inc. 0.22
    TNXP F Tonix Pharmaceuticals Holding Corp. 7.83
    SEEL F Seelos Therapeutics, Inc. -7.78
    REGN B Regeneron Pharmaceuticals, Inc. 0.68
    PXMD F PaxMedica, Inc. -9.53
    PTPI F Petros Pharmaceuticals, Inc. 2.12
    PHAT D Phathom Pharmaceuticals, Inc. 6.10
    OVID F Ovid Therapeutics Inc. 4.97
    ONCO F Onconetix, Inc. -4.45
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Medicine Biopharmaceutical Psychiatric Diagnosis Schizophrenia Alcohol Alzheimer's Disease Bipolar Disorder Cannabis Clinical Medicine Cognitive Disorders Diabetes Disease Dystrophy Epilepsy Hemoglobin Insomnia Mental Health Movement Disorders Organ Systems Pain

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    PBE B PowerShares Dynamic Biotech & Genome 10.09
    IBRN F iShares Neuroscience and Healthcare ETF 9.2
    FBT C First Trust Amex Biotech Index Fund 6.77
    BBP B BioShares Biotechnology Products Fund 5.79
    XPH D SPDR S&P Pharmaceuticals ETF 5.01
    View all Disorders ETFs...
    Compare ETFs
    Compare FBT to XPH Compare IBRN to BBP Compare PBE to FBT

        Disorders Stocks Recent News

        Date Stock Title
        May 14 OVID Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
        May 13 TNXP Tonix Pharmaceuticals GAAP EPS of -$0.18 beats by $0.16, revenue of $2.48M misses by $1.39M
        May 13 TNXP Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
        May 13 XGN Exagen, Inc. (XGN) Q1 2024 Earnings Call Transcript
        May 13 PHAT Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript
        May 13 REGN Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
        May 13 REGN Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
        May 13 XGN Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
        May 13 XGN Exagen beats top-line and bottom-line estimates; raises FY24 outlook
        May 13 XGN Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
        May 13 OVID Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
        May 13 REGN Pipeline Moves: Phase III completion for Corcept’s relaorilant
        May 13 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
        May 11 PHAT Phathom Pharmaceuticals, Inc. (PHAT) Q1 2024 Earnings Call Transcript
        May 10 REGN Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
        May 10 REGN Q1 2024 Intellia Therapeutics Inc Earnings Call
        May 9 PHAT Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
        May 9 PHAT Phathom Pharmaceuticals Non-GAAP EPS of -$1.11 beats by $0.06, revenue of $1.91M misses by $0.23M
        May 9 PHAT Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
        May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Medicine Biopharmaceutical Psychiatric Diagnosis Schizophrenia Alcohol Alzheimer's Disease Bipolar Disorder Cannabis Clinical Medicine Cognitive Disorders Diabetes Disease Dystrophy Epilepsy Hemoglobin Insomnia Mental Health Movement Disorders Organ Systems Pain
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags